Telomerix Stem Cell Biobank
Telomerix Stem Cell Biobank is the first private stem cell bank in Virginia, committed to providing advanced stem cell recovery and cryopreservation using state-of-the-art technology. They focus on handling each collection with care to ensure high-quality stem cells for potential life-saving treatments. Their mission is to improve treatment outcomes for chronic and degenerative diseases through innovative stem cell preservation and research. They also explore the promising use of mesenchymal stem cell (MSC) infusion therapy for combating COVID-19-induced pneumonia, demonstrating their commitment to cutting-edge regenerative medicine and therapeutic solutions.
Industries
Nr. of Employees
small (1-50)
Telomerix Stem Cell Biobank
Chesapeake, Virginia, United States, North America
Products
Cord blood banking package (example listing)
Commercial package that includes collection kit shipping, laboratory processing, initial storage term and optional multi-year storage upgrades.
Cord tissue / MSC banking package (example listing)
Processing and storage offering for cord tissue-derived mesenchymal cells; available standalone or combined with cord blood banking.
Adipose-derived stem cell banking package (example listing)
Processing and cryopreservation offering for adipose-derived cells with multi-year storage plans.
Platelet-rich plasma (PRP) service
Clinical PRP preparation service for musculoskeletal and tissue repair applications.
Cord blood banking package (example listing)
Commercial package that includes collection kit shipping, laboratory processing, initial storage term and optional multi-year storage upgrades.
Cord tissue / MSC banking package (example listing)
Processing and storage offering for cord tissue-derived mesenchymal cells; available standalone or combined with cord blood banking.
Adipose-derived stem cell banking package (example listing)
Processing and cryopreservation offering for adipose-derived cells with multi-year storage plans.
Platelet-rich plasma (PRP) service
Clinical PRP preparation service for musculoskeletal and tissue repair applications.
Services
Kit-based collection at delivery, laboratory processing to recover hematopoietic cells, and long-term cryostorage offered as a commercial service.
Processing and cryopreservation of cord tissue to preserve mesenchymal stromal/stem cells for potential future therapeutic or research use.
Processing and cryopreservation of stem/progenitor cells isolated from adipose tissue with multi-year storage options.
Clinical preparation of autologous PRP products for indications such as musculoskeletal repair and cosmetic applications.
Provision of collection kits, chain-of-custody workflows and courier shipping included with processing packages.
Fixed-price processing and storage packages with multiple term options and third-party financing for customers.
Kit-based collection at delivery, laboratory processing to recover hematopoietic cells, and long-term cryostorage offered as a commercial service.
Processing and cryopreservation of cord tissue to preserve mesenchymal stromal/stem cells for potential future therapeutic or research use.
Processing and cryopreservation of stem/progenitor cells isolated from adipose tissue with multi-year storage options.
Clinical preparation of autologous PRP products for indications such as musculoskeletal repair and cosmetic applications.
Provision of collection kits, chain-of-custody workflows and courier shipping included with processing packages.
Fixed-price processing and storage packages with multiple term options and third-party financing for customers.
Expertise Areas
- Cord blood biobanking
- Mesenchymal stromal/stem cell processing and preservation
- Adipose-derived cell processing and storage
- Autologous platelet-rich plasma preparation
Key Technologies
- Cryopreservation and controlled-rate freezing
- Cell isolation and cell sorting
- Umbilical cord blood processing
- Cord tissue MSC recovery and cryostorage
News & Updates
A study by Dr. Zhao and collaborators demonstrated that intravenous infusion of clinical-grade human MSCs led to significant improvement in COVID-19 pneumonia patients, including elderly patients with severe conditions, with symptoms subsiding within 2-4 days and no adverse effects observed.
Discussion on the benefits and risks of COVID-19 vaccines in relation to pregnancy and fertility.
Market survey showing the growing traction of stem cells in research, especially in oncology.
Studies and clinical trials exploring the use of mesenchymal stem cells for treating COVID-19 complications.
Research at UPMC Pittsburgh shows that infusing umbilical cord blood is safe and effective for treating children with genetic disorders.
Promising results from clinical trials using newborn stem cells to improve survival in COVID-19 patients.
A study by Dr. Zhao and collaborators demonstrated that intravenous infusion of clinical-grade human MSCs led to significant improvement in COVID-19 pneumonia patients, including elderly patients with severe conditions, with symptoms subsiding within 2-4 days and no adverse effects observed.
Discussion on the benefits and risks of COVID-19 vaccines in relation to pregnancy and fertility.
Market survey showing the growing traction of stem cells in research, especially in oncology.
Studies and clinical trials exploring the use of mesenchymal stem cells for treating COVID-19 complications.
Research at UPMC Pittsburgh shows that infusing umbilical cord blood is safe and effective for treating children with genetic disorders.
Promising results from clinical trials using newborn stem cells to improve survival in COVID-19 patients.